Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines

ABSTRACT: Decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, is tested in combination with conventional anticancer drugs as a treatment option for various solid tumors.

ORGANISM(S): Homo sapiens

SUBMITTER: Eleftherios Pilalis 

PROVIDER: E-MTAB-12225 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress